Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)
Published in:
Forum Diab 2022; 11(Supplementum 1): 23-55
Category:
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
![Issue Supplementum 1](https://www.forumdiabetologicum.sk/media/cache/resolve/journal_issue/media/image_pdf/6ccc8d3d909139ad2cd3cb251dcff50c.jpg)
2022 Issue Supplementum 1
Most read in this issue
- Rationalisation of previous multiple insulin treatment by switching to a fixed combination of basal insulin degludec and the GLP1-receptor agonist liraglutide (IDegLira): results of the SIMPLIFY study after 14 weeks
- Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)
- Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)
- Simplification of previous multiple insulin treatment by switching to a fixed combination of basal insulin degludec and GLP1-receptor agonist liraglutide: SIMPLIFY study Evaluation of the early outcome questionnaires